$OPEN
Opendoor Technologies Inc. Stock $open

$open Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000180116922000027 Filed on February 24, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$3.822B	$8.021B	$248.9M
YoY Change	1435.64%	210.53%	-80.18%
Cost Of Revenue	$3.550B	$7.291B	$210.5M
YoY Change	1586.64%	208.55%	-82.19%
Gross Profit	$271.6M	$730.0M	$38.37M
YoY Change	607.96%	231.82%	-48.13%
Gross Profit Margin	7.11%	9.1%	15.41%
Selling, General & Admin	$342.1M	$1.164B	$92.10M
YoY Change	271.46%	234.48%	-26.73%
% of Gross Profit	125.96%	159.45%	240.06%
Research & Development	$31.84M	$134.0M	$12.40M
YoY Change	156.77%	131.03%	-11.43%
% of Gross Profit	11.72%	18.36%	32.32%
Depreciation & Amortization	$20.45M	$27.00M	$7.500M
YoY Change	172.65%	22.73%	-15.73%
% of Gross Profit	7.53%	3.7%	19.55%
Operating Expenses	$374.0M	$1.298B	$104.5M
YoY Change	257.85%	219.7%	-25.2%
Operating Profit	-$102.3M	-$568.0M	-$66.13M
YoY Change	54.75%	205.38%	0.6%
Interest Expense	-$72.80M	$143.0M	-$11.10M
YoY Change	555.89%	110.29%	-61.72%
% of Operating Profit
Other Income/Expense, Net	-$15.60M	$38.00M	$700.0K
YoY Change	-2328.71%	850.0%	-76.67%
Pretax Income	-$190.6M	-$661.0M	-$88.00M
YoY Change	116.53%	161.26%	-4.14%
Income Tax	$390.0K	$1.000M	-$200.0K
% Of Pretax Income
Net Earnings	-$190.9M	-$662.0M	-$87.79M
YoY Change	117.49%	161.66%	-4.28%
Net Earnings / Revenue	-5.0%	-8.25%	-35.27%
Basic Earnings Per Share		-$1.12	-$0.49
Diluted Earnings Per Share	-$311.6K	-$1.12	-$0.49
COMMON SHARES
Basic Shares Outstanding	612.6M shares	592.6M shares
Diluted Shares Outstanding		592.6M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.215B	$2.215B	$1.461B
YoY Change	51.65%	51.68%	225.62%
Cash & Equivalents	$1.731B	$1.731B	$1.413B
Short-Term Investments	$484.0M	$484.0M	$47.64M
Other Short-Term Assets	$91.00M	$945.0M	$24.00M
YoY Change	279.17%	701.53%	-22.28%
Inventory	$6.096B	$6.096B	$465.9M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$9.340B	$9.340B	$2.053B
YoY Change	354.94%	354.92%	-1.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.00M	$87.00M	$29.00M
YoY Change	55.17%	10.55%	-16.2%
Goodwill	$60.00M		$31.00M
YoY Change	93.55%		0.18%
Intangibles	$12.00M		$9.000M
YoY Change	33.33%		-27.5%
Long-Term Investments
YoY Change
Other Assets	$7.000M	$7.000M	$4.000M
YoY Change	75.0%	70.73%	-25.84%
Total Long-Term Assets	$166.0M	$166.0M	$123.0M
YoY Change	34.96%	35.51%	-14.61%
TOTAL ASSETS
Total Short-Term Assets	$9.340B	$9.340B	$2.053B
Total Long-Term Assets	$166.0M	$166.0M	$123.0M
Total Assets	$9.506B	$9.506B	$2.176B
YoY Change	336.86%	336.94%	-2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.000M	$3.000M	$2.800M
YoY Change	7.14%	7.14%
Accrued Expenses	$66.00M	$141.0M	$11.00M
YoY Change	500.0%	258.78%	-32.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.247B	$4.247B	$346.3M
YoY Change	1126.32%	1126.39%	-67.76%
Total Short-Term Liabilities	$4.400B	$4.400B	$393.0M
YoY Change	1019.59%	1018.45%	-65.11%
LONG-TERM LIABILITIES
Long-Term Debt	$2.816B	$2.816B	$135.5M
YoY Change	1978.23%	1978.23%
Other Long-Term Liabilities	$42.00M	$42.00M	$94.00K
YoY Change	44580.85%	-10.06%	-54.81%
Total Long-Term Liabilities	$2.858B	$2.858B	$94.00K
YoY Change	3040325.53%	1468.61%	-54.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.400B	$4.400B	$393.0M
Total Long-Term Liabilities	$2.858B	$2.858B	$94.00K
Total Liabilities	$7.258B	$7.258B	$623.0M
YoY Change	1065.01%	1160.95%	-60.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.705B		-$1.043B
YoY Change	63.47%		31.94%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.248B	$2.248B	$1.600B
YoY Change
Total Liabilities & Shareholders Equity	$9.506B	$9.506B	$2.176B
YoY Change	336.86%	336.94%	-2.5%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$190.9M	-$662.0M	-$87.79M
YoY Change	117.49%	161.66%	-4.28%
Depreciation, Depletion And Amortization	$20.45M	$27.00M	$7.500M
YoY Change	172.65%	22.73%	-15.73%
Cash From Operating Activities	$109.6M	-$5.794B	-$355.5M
YoY Change	-130.82%	-949.56%	-973.46%
INVESTING ACTIVITIES
Capital Expenditures	-$10.33M	$33.00M	-$5.200M
YoY Change	98.69%	94.12%	-16.13%
Acquisitions		$33.00M
YoY Change
Other Investing Activities	-$33.84M	-$442.0M	$34.30M
YoY Change	-198.67%	9722.22%	-468.82%
Cash From Investing Activities	-$44.18M	-$476.0M	$28.90M
YoY Change	-252.85%	2063.64%	-286.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$886.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	668.9M	$7.342B	1.189B
YoY Change	-43.72%	4460.25%	31176.32%
NET CHANGE
Cash From Operating Activities	109.6M	-$5.794B	-355.5M
Cash From Investing Activities	-44.18M	-$476.0M	28.90M
Cash From Financing Activities	668.9M	$7.342B	1.189B
Net Change In Cash	734.3M	$1.072B	861.9M
YoY Change	-14.81%	30.57%	2872.07%
FREE CASH FLOW
Cash From Operating Activities	$109.6M	-$5.794B	-$355.5M
Capital Expenditures	-$10.33M	$33.00M	-$5.200M
Free Cash Flow	$119.9M	-$5.827B	-$350.3M
YoY Change	-134.22%	-976.24%	-846.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001801169
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	open	Class Of Warrant Or Right Trading Day Period Used To Determine Reference Value On The Last Reported Sales Price Of Common Stock ClassOfWarrantOrRightTradingDayPeriodUsedToDetermineReferenceValueOnTheLastReportedSalesPriceOfCommonStock	P30D
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39253
CY2021	dei	Entity Registrant Name EntityRegistrantName	Opendoor Technologies Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1515020
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	410 N. Scottsdale Road,
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1600
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Tempe,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85281
CY2021	dei	City Area Code CityAreaCode	415
CY2021	dei	Local Phone Number LocalPhoneNumber	896-6737
CY2021	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
CY2021	dei	Trading Symbol TradingSymbol	OPEN
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	8530606083	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	620131694	shares
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1731000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1413000000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	847000000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	93000000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	484000000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	48000000	USD
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	84000000	USD
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	1000000	USD
CY2021Q4	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	7000000	USD
CY2020Q4	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	8000000	USD
CY2021Q4	us-gaap	Inventory Real Estate InventoryRealEstate	6096000000	USD
CY2020Q4	us-gaap	Inventory Real Estate InventoryRealEstate	466000000	USD
CY2021Q4	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	4000000	USD
CY2020Q4	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	0	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	91000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9340000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2053000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	42000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	50000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	60000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	31000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9000000	USD
CY2021Q4	open	Other Assets Noncurrent Fair Value Disclosure OtherAssetsNoncurrentFairValueDisclosure	5000000	USD
CY2020Q4	open	Other Assets Noncurrent Fair Value Disclosure OtherAssetsNoncurrentFairValueDisclosure	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4000000	USD
CY2021Q4	us-gaap	Assets Assets	9506000000	USD
CY2020Q4	us-gaap	Assets Assets	2176000000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	137000000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	25000000	USD
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4240000000	USD
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	339000000	USD
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	7000000	USD
CY2020Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	7000000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4400000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	393000000	USD
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1862000000	USD
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	136000000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	954000000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	47000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	47000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	7258000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	623000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	616026565	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	540714692	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	616026565	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	540714692	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3955000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2596000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1705000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1043000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2248000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1553000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9506000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2176000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8021000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2583000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4741000000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	7291000000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	2363000000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	4440000000	USD
CY2021	us-gaap	Gross Profit GrossProfit	730000000	USD
CY2020	us-gaap	Gross Profit GrossProfit	220000000	USD
CY2019	us-gaap	Gross Profit GrossProfit	301000000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	544000000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	195000000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	384000000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	620000000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	153000000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114000000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	134000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-662000000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58000000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51000000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	1298000000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	406000000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	549000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-568000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-186000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-248000000	USD
CY2021	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-12000000	USD
CY2020	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-8000000	USD
CY2019	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-6000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Interest Expense InterestExpense	143000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	68000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	110000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	38000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-661000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-253000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-339000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-253000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-341000000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.31
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.26
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.31
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.37
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	592574000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109301000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79977000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	592574000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109301000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79977000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-664000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-253000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-339000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-664000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-253000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-341000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-414000000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7000000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000000	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4000000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000000	USD
CY2019	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	5000000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-733000000	USD
CY2020	open	Adjustments To Additional Paid In Capital Issuance Of Issuer Stock Rights In Extinguishment Of Convertible Notes AdjustmentsToAdditionalPaidInCapitalIssuanceOfIssuerStockRightsInExtinguishmentOfConvertibleNotes	213000000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8000000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1386000000	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	889000000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1553000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1553000000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	857000000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	58000000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000000	USD
CY2021	open	Adjustments To Additional Paid In Capital Purchase Of Options Indexed To Issuers Equity AdjustmentsToAdditionalPaidInCapitalPurchaseOfOptionsIndexedToIssuersEquity	119000000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	548000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2248000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2021	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	47000000	USD
CY2020	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	39000000	USD
CY2019	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	27000000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8000000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	24000000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	12000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	536000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	38000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	13000000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12000000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-31000000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6000000	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	5000000	USD
CY2020	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2019	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	56000000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	8000000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	32000000	USD
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-23000000	USD
CY2019	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1000000	USD
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	35000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	646000000	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2019	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	4000000	USD
CY2019	us-gaap	Paid In Kind Interest PaidInKindInterest	2000000	USD
CY2021	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	4000000	USD
CY2020	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	3000000	USD
CY2019	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	0	USD
CY2021	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	196000000	USD
CY2020	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	128000000	USD
CY2019	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	23000000	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	197000000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	126000000	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	22000000	USD
CY2021	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	83000000	USD
CY2020	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	-12000000	USD
CY2019	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	3000000	USD
CY2021	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	5656000000	USD
CY2020	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-834000000	USD
CY2019	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-17000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	52000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	76000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5000000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4000000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3000000	USD
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2021	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-13000000	USD
CY2020	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-7000000	USD
CY2019	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-14000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5794000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	682000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-272000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28000000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	486000000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	175000000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	79000000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	92000000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	170000000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	45000000	USD
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	15000000	USD
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	5838000000	USD
CY2020	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	USD
CY2019	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	33000000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	33000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-476000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95000000	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	953000000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	178000000	USD
CY2021	open	Payments For Option Indexed To Issuers Equity PaymentsForOptionIndexedToIssuersEquity	119000000	USD
CY2020	open	Payments For Option Indexed To Issuers Equity PaymentsForOptionIndexedToIssuersEquity	0	USD
CY2019	open	Payments For Option Indexed To Issuers Equity PaymentsForOptionIndexedToIssuersEquity	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15000000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2578000000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000000	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	22000000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	open	Proceeds From Business Combination And Pipe Offering ProceedsFromBusinessCombinationAndPIPEOffering	0	USD
CY2020	open	Proceeds From Business Combination And Pipe Offering ProceedsFromBusinessCombinationAndPIPEOffering	1014000000	USD
CY2019	open	Proceeds From Business Combination And Pipe Offering ProceedsFromBusinessCombinationAndPIPEOffering	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	886000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3000000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	11499000000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1309000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	3641000000	USD
CY2020	open	Non Cash Activities Stock Issued During Period Value Acquisitions NonCashActivitiesStockIssuedDuringPeriodValueAcquisitions	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2130000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3475000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	192000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	125000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	23000000	USD
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	192000000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	121000000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	21000000	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	47000000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3000000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	15000000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7342000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1072000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	821000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	279000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1506000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	685000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	406000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2578000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1506000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	685000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	122000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	57000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	86000000	USD
CY2021	open	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	0	USD
CY2020	open	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	1386000000	USD
CY2019	open	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	0	USD
CY2021	open	Issuance Of Issuer Stock Rights In Extinguishment Convertible Notes IssuanceOfIssuerStockRightsInExtinguishmentConvertibleNotes	0	USD
CY2020	open	Issuance Of Issuer Stock Rights In Extinguishment Convertible Notes IssuanceOfIssuerStockRightsInExtinguishmentConvertibleNotes	213000000	USD
CY2019	open	Non Cash Activities Stock Issued During Period Value Acquisitions NonCashActivitiesStockIssuedDuringPeriodValueAcquisitions	7000000	USD
CY2019	open	Issuance Of Issuer Stock Rights In Extinguishment Convertible Notes IssuanceOfIssuerStockRightsInExtinguishmentConvertibleNotes	0	USD
CY2021	open	Non Cash Activities Stock Issued During Period Value Acquisitions NonCashActivitiesStockIssuedDuringPeriodValueAcquisitions	0	USD
CY2021	open	Recognition Of Warrant Liability RecognitionOfWarrantLiability	0	USD
CY2020	open	Recognition Of Warrant Liability RecognitionOfWarrantLiability	81000000	USD
CY2019	open	Recognition Of Warrant Liability RecognitionOfWarrantLiability	0	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	35000000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1731000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1413000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	405000000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	847000000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	93000000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	280000000	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1506000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	685000000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	47000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	623000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2596000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1043000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1553000000	USD
CY2020	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-8000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-253000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.31
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.31
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2596000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1043000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1553000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-31000000	USD
CY2020	open	Recognition Of Warrant Liability RecognitionOfWarrantLiability	81000000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ materially from such estimates. Significant estimates, assumptions and judgments made by management include, among others, </span></div>the determination of the fair value of common stock, share-based awards, warrants, derivatives, and inventory valuation adjustment. Management believes that the estimates and judgments upon which they rely are reasonable based upon information available to them at the time that these estimates and judgments are made. To the extent that there are material differences between these estimates and actual results, the Company’s financial statements will be affected. The COVID-19 pandemic introduced significant additional uncertainties with respect to estimates, judgments and assumptions, which may materially impact these estimates.
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, investments in marketable securities, and mortgage loans held for sale pledged under agreements to repurchase (“MLHFS”). The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company’s investments.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, the Company’s credit risk on mortgage loans held for sale is mitigated due to having a large number of customers. Further, the Company’s credit risk on mortgage loans held for sale is mitigated by the fact that the Company typically sells mortgages on the secondary market within a relatively short period of time after which the Company’s exposure is limited to borrower defaults within the initial few months of the mortgage.</span></div>
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2000000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4000000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	open	Number Of Days Of Guarantee On Home Sales NumberOfDaysOfGuaranteeOnHomeSales	P90D
CY2021	us-gaap	Advertising Expense AdvertisingExpense	123000000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	33000000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	75000000	USD
CY2021Q3	open	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.10
CY2020Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	183000000	USD
CY2021Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1971000000	USD
CY2021Q4	open	Inventory Real Estate Finished Goods InventoryRealEstateFinishedGoods	4125000000	USD
CY2020Q4	open	Inventory Real Estate Finished Goods InventoryRealEstateFinishedGoods	283000000	USD
CY2021Q4	us-gaap	Inventory Real Estate InventoryRealEstate	6096000000	USD
CY2020Q4	us-gaap	Inventory Real Estate InventoryRealEstate	466000000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	46000000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	46000000	USD
CY2021Q4	open	Equity Securities Fvni Cash And Cash Equivalents EquitySecuritiesFVNICashAndCashEquivalents	0	USD
CY2021Q4	open	Equity Securities Fvni Marketable Securities EquitySecuritiesFVNIMarketableSecurities	46000000	USD
CY2021Q4	open	Cash Cash Equivalents And Marketable Securities Amortized Cost CashCashEquivalentsAndMarketableSecuritiesAmortizedCost	2216000000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45000000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000000	USD
CY2021Q4	open	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	2215000000	USD
CY2021Q4	open	Marketable Securities Cash And Cash Equivalents MarketableSecuritiesCashAndCashEquivalents	1731000000	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	484000000	USD
CY2020Q4	open	Cash Cash Equivalents And Marketable Securities Amortized Cost CashCashEquivalentsAndMarketableSecuritiesAmortizedCost	1461000000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	open	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	1461000000	USD
CY2020Q4	open	Debt Securities Available For Sale Cash And Cash Equivalents DebtSecuritiesAvailableForSaleCashAndCashEquivalents	1413000000	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	48000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	497000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	497000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	31000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	31000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	238000000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	102000000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	136000000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5000000	USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	35000000	USD
CY2021Q3	open	Option Indexed To Issuers Equity Cap Price Premium OptionIndexedToIssuersEquityCapPricePremium	1
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	102000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63000000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57000000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P11Y
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	12000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	34000000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	12000000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1000000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1000000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1000000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	1000000	USD
CY2021	us-gaap	Lease Cost LeaseCost	12000000	USD
CY2020	us-gaap	Lease Cost LeaseCost	35000000	USD
CY2019	us-gaap	Lease Cost LeaseCost	14000000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	10000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	13000000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	11000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	40000000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	58000000	USD
CY2020	open	Reduction In Right Of Use Assets And Liabilities Due To Termination Of Operating Leases ReductionInRightOfUseAssetsAndLiabilitiesDueToTerminationOfOperatingLeases	28000000	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	5000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y7M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.098
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.091
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	27000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	67000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46000000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	29000000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12000000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	66000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11000000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	24000000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1000000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	18000000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	4000000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6000000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3000000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3000000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	137000000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	25000000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	195000000	shares
CY2020Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0	shares
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24158000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	503000000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	150000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.00
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8919000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.65
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	840000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.77
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.98
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14546000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.12
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	182000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12793000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.79
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M18D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	164000000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	144000000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	46000000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10000000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.18
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.50
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0	shares
CY2020Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021	open	Class Of Warrants And Rights Redemption Price Per Share ClassOfWarrantsAndRightsRedemptionPricePerShare	0.01
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	536000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	15.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.73
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0109
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q4	open	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	19933333	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	22000000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-661000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-253000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-339000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	1000000	USD
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	open	Effective Income Tax Rate Reconciliation Tax Expense Benefit Loss On Convertible Note Exchange Percent EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitLossOnConvertibleNoteExchangePercent	0
CY2020	open	Effective Income Tax Rate Reconciliation Tax Expense Benefit Loss On Convertible Note Exchange Percent EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitLossOnConvertibleNoteExchangePercent	-0.024
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.034
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.032
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.001
CY2021	open	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Expenses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantExpenses	0.004
CY2020	open	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Expenses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantExpenses	0.030
CY2019	open	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Expenses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantExpenses	0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.004
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.004
CY2019	open	Effective Income Tax Rate Reconciliation Tax Expense Benefit Loss On Convertible Note Exchange Percent EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitLossOnConvertibleNoteExchangePercent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.070
CY2021	open	Effective Income Tax Rate Reconciliation Limitation On Executive Compensation Percent EffectiveIncomeTaxRateReconciliationLimitationOnExecutiveCompensationPercent	-0.141
CY2020	open	Effective Income Tax Rate Reconciliation Limitation On Executive Compensation Percent EffectiveIncomeTaxRateReconciliationLimitationOnExecutiveCompensationPercent	-0.021
CY2019	open	Effective Income Tax Rate Reconciliation Limitation On Executive Compensation Percent EffectiveIncomeTaxRateReconciliationLimitationOnExecutiveCompensationPercent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.195
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.239
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.252
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.020
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.010
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	21000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	4000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	34000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	33000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13000000	USD
CY2021Q4	open	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	11000000	USD
CY2020Q4	open	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	16000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	293000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	206000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	392000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	250000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	1000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	10000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	12000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	235000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	235000000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	141000000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	60000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1200000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	854000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	9000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	14000000	USD
CY2019	us-gaap	Dividends Dividends	0	USD
CY2021	us-gaap	Dividends Dividends	0	USD
CY2020	us-gaap	Dividends Dividends	0	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-662000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-253000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-341000000	USD
CY2020	open	Dilutive Securities Effect On Basic Earnings Per Share Classified Warrants Gain On Liability DilutiveSecuritiesEffectOnBasicEarningsPerShareClassifiedWarrantsGainOnLiability	0	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	592574000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	592574000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109301000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109301000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79977000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79977000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.31
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.26
CY2021	us-gaap	Profit Loss ProfitLoss	-662000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-253000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-339000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	open	Dilutive Securities Effect On Basic Earnings Per Share Classified Warrants Gain On Liability DilutiveSecuritiesEffectOnBasicEarningsPerShareClassifiedWarrantsGainOnLiability	0	USD
CY2019	open	Dilutive Securities Effect On Basic Earnings Per Share Classified Warrants Gain On Liability DilutiveSecuritiesEffectOnBasicEarningsPerShareClassifiedWarrantsGainOnLiability	8000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-662000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-253000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-349000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	592574000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	592574000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109301000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109301000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79977000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79977000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.31
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.37
CY2019	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	68688000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	92821000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	381643000	shares
CY2021Q4	us-gaap	Recorded Unconditional Purchase Obligation Minimum Quantity Required RecordedUnconditionalPurchaseObligationMinimumQuantityRequired	5411	home
CY2021Q4	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	1900000000	USD
CY2021	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
0001801169-22-000027-index-headers.html	Edgar Link	pending
0001801169-22-000027-index.html	Edgar Link	pending
0001801169-22-000027.txt	Edgar Link	pending
0001801169-22-000027-xbrl.zip	Edgar Link	pending
a202110-kexhibit311.htm	Edgar Link	pending
a202110-kexhibit312.htm	Edgar Link	pending
a202110-kexhibit321.htm	Edgar Link	pending
a2021ex1015opendoortechnol.htm	Edgar Link	pending
a2021ex1016offerletterdate.htm	Edgar Link	pending
a2021ex211xlistofsubsidiar.htm	Edgar Link	pending
a2021ex231xconsentofdeloit.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
open-20211231.htm	Edgar Link	pending
open-20211231.xsd	Edgar Link	pending
open-20211231_cal.xml	Edgar Link	unprocessable
open-20211231_def.xml	Edgar Link	unprocessable
open-20211231_htm.xml	Edgar Link	completed
open-20211231_lab.xml	Edgar Link	unprocessable
open-20211231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPEN
Opendoor Technologies Inc. Stock $open

2021 Q4 Form 10-K Financial Statement

#000180116922000027 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN Opendoor Technologies Inc. Stock $open

2021 Q4 Form 10-K Financial Statement

#000180116922000027 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN
Opendoor Technologies Inc. Stock $open